Conventional and complementary alternative medicine therapies for renal anemia: a literature review

Front Endocrinol (Lausanne). 2025 Jan 22:15:1342873. doi: 10.3389/fendo.2024.1342873. eCollection 2024.

Abstract

Renal anemia stems mainly from chronic inflammation with elevated hepcidin levels, iron deficiency, and reduced red blood cell lifespan. Inadequate erythropoietin (EPO) production, worsened kidney function, leads to symptoms such as low energy, fatigue, and impaired physical function, significantly affecting patients' quality of life. We conducted a comprehensive search across electronic databases including PubMed, Embase, Cochrane Library, Chinese National Knowledge Infrastructure, Airiti library, and Wanfang, to compile recent clinical trials and pilot studies on conventional and complementary alternative medicine approaches for renal anemia. This discussion focuses on the hypoxia-inducible factor prolyl hydroxylase domain (HIF-PHD) axis theory, from lab research to clinical applications. It explores non-extracorporeal treatments for renal anemia, including pharmaceutical interventions, dietary strategies, and complementary and alternative medicine (CAM). The article details the effects of Roxadustat, Ferumoxytol, and Epodion. Clinical studies show that modulating the gut microbiome can reduce inflammation and improve renal anemia. Clinical trials suggest that CAM therapy can improve renal anemia through mechanisms such as enhanced iron metabolism, anti-inflammatory effects, reduced hepcidin levels, and increased EPO and HIF expressions. By synthesizing this information, the review aims to furnish valuable insights and treatment recommendations aimed at ameliorating renal anemia in individuals grappling with chronic kidney disease.

Keywords: chronic kidney disease; complementary and alternative medicine; conventional medical therapy; diet control; dietary supplement; renal anemia.

Publication types

  • Review

MeSH terms

  • Anemia* / etiology
  • Anemia* / therapy
  • Complementary Therapies* / methods
  • Humans
  • Renal Insufficiency, Chronic* / complications
  • Renal Insufficiency, Chronic* / therapy

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study received financial support from the Buddhist Tzu Chi Medical Foundation, Taiwan (Grant Number: TCMF-CM1-111-03) and Taipei Tzu Chi Hospital (TCRD-TPE-111-07, TCRD-TPE-113-07, and TCRD-TPE-NSTC-113-06).